Niiya F, Tamai N, Yamawaki M, Noda J, Azami T, Takano Y, Nishimoto F, Nagahama M. Benefits of endoscopic gallbladder stenting following percutaneous transhepatic gallbladder drainage. World J Gastrointest Surg 2024; 16(9): 2902-2909 [PMID: 39351569 DOI: 10.4240/wjgs.v16.i9.2902]
Corresponding Author of This Article
Yuichi Takano, MD, Chief Doctor, Division of Gastroenterology, Department of Internal Medicine, Showa University Fujigaoka Hospital, 1-30 Fujigaoka, Aoba-ku, Yokohama 227-8501, Kanagawa, Japan. yuichitakano1028@yahoo.co.jp
Research Domain of This Article
Gastroenterology & Hepatology
Article-Type of This Article
Retrospective Study
Open-Access Policy of This Article
This article is an open-access article which was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/
Fumitaka Niiya, Naoki Tamai, Masataka Yamawaki, Jun Noda, Tetsushi Azami, Yuichi Takano, Fumiya Nishimoto, Masatsugu Nagahama, Division of Gastroenterology, Department of Internal Medicine, Showa University Fujigaoka Hospital, Yokohama 227-8501, Kanagawa, Japan
Author contributions: Niiya F, Nishimoto F, Tamai N, Yamawaki M, and Noda J acquired patient data, and Azami T prepared the manuscript and figures; Takano Y and Nagahama M participated in data acquisition and analysis; All authors agree with the contents of this manuscript.
Institutional review board statement: Ethical compliance was ensured in accordance with the guidelines set by the hospital’s Institutional Review Board (No. 2024-073-A), and the study was conducted in accordance with the tenets of the Declaration of Helsinki.
Informed consent statement: All of the participants provided informed consent prior to their inclusion to the study.
Conflict-of-interest statement: All the authors report no relevant conflicts of interest for this article.
Data sharing statement: No additional data are available.
Open-Access: This article is an open-access article that was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution NonCommercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: https://creativecommons.org/licenses/by-nc/4.0/
Corresponding author: Yuichi Takano, MD, Chief Doctor, Division of Gastroenterology, Department of Internal Medicine, Showa University Fujigaoka Hospital, 1-30 Fujigaoka, Aoba-ku, Yokohama 227-8501, Kanagawa, Japan. yuichitakano1028@yahoo.co.jp
Received: June 13, 2024 Revised: July 10, 2024 Accepted: August 5, 2024 Published online: September 27, 2024 Processing time: 97 Days and 8.7 Hours
Abstract
BACKGROUND
Endoscopic transpapillary gallbladder drainage is challenging because of the complexity of the procedure and high incidence of adverse events (AEs). To overcome these problems, endoscopic gallbladder stenting (EGBS) after percutaneous transhepatic gallbladder drainage (PTGBD) can be effective, as it mitigates inflammation and adhesion.
AIM
To examine the benefits of EGBS after PTGBD to assess its efficacy and impact on AEs.
METHODS
We retrospectively analyzed data from 35 patients who underwent EGBS after PTGBD at a single center between January 2016 and December 2023. The primary outcomes were technical success and AEs, and the rate of recurrent cholecystitis was evaluated. In addition, the reasons for the failure of the procedure were identified.
RESULTS
Among the 35 patients, the technical success rate was 77.1% and the final contrast of the cystic duct was successful in 97.1% of patients. The incidence of early AEs was relatively low (11.4%), with no instances of cystic duct perforation. The rate of recurrent cholecystitis was 3.7%, and no other biliary events were observed.
CONCLUSION
EGBS after PTGBD may be significantly beneficial, with a substantial success rate and minimal AEs in both short- and long-term follow-ups.
Core Tip: The placement of gallbladder stents is considered a technically challenging procedure and is only recommended in specialized facilities. Our findings suggest that endoscopic gallbladder stenting after percutaneous transhepatic gallbladder drainage may simplify this technique. This approach has the potential to reduce the risk of adverse events, both immediately after the procedure and in the long term, and may be beneficial for patients with a high surgical risk. This is the first study to investigate endoscopic gallbladder stenting after percutaneous transhepatic gallbladder drainage, which may have possible implications as a technique that could be a valuable addition to clinical treatment strategies.
